| scholarly article | Q13442814 |
| P50 | author | Jennifer Wheler | Q130684247 |
| Agop Y Bedikian | Q130684257 | ||
| Luis H Camacho | Q37391549 | ||
| Razelle Kurzrock | Q56614941 | ||
| Apostolia Maria Tsimberidou | Q56761627 | ||
| Siqing Fu | Q56890248 | ||
| Sijin Wen | Q88490018 | ||
| Chaan S Ng | Q99613408 | ||
| P2093 | author name string | David Hong | |
| Michael Wallace | |||
| Cathy Eng | |||
| Jo Ann Lim | |||
| P2860 | cites work | New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada | Q27860904 |
| Phase I and pharmacokinetic study of hepatic arterial infusion with oxaliplatin in combination with folinic acid and 5-fluorouracil in patients with hepatic metastases from colorectal cancer | Q33337948 | ||
| Hepatic arterial infusion of oxaliplatin and L-folinic acid-modulated 5-fluorouracil for colorectal cancer liver metastases | Q33371404 | ||
| Hepatic arterial chemotherapy in metastatic colorectal patients | Q33755633 | ||
| A systematic overview of chemotherapy effects in colorectal cancer | Q34301222 | ||
| Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer | Q34506398 | ||
| Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial. | Q34557866 | ||
| Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer | Q34559194 | ||
| Hepatic-arterial chemotherapy | Q34571953 | ||
| A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial | Q34665442 | ||
| Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial | Q34683968 | ||
| A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases | Q34684005 | ||
| Surgical treatment of colorectal cancer metastasis. | Q35682117 | ||
| Hepatic arterial infusion chemotherapy for metastatic colorectal cancer: a concise overview | Q35832101 | ||
| Systemic therapy for metastatic colorectal cancer: current options, current evidence | Q36186140 | ||
| Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma | Q36822114 | ||
| Surgical therapy for colorectal metastases to the liver | Q36832322 | ||
| Modern multimodality approach to hepatic colorectal metastases: solutions and controversies | Q36833292 | ||
| Regional chemotherapy for liver-limited metastatic colorectal cancer | Q37225000 | ||
| The role of floxuridine in metastatic liver disease | Q37454073 | ||
| Acute oxaliplatin-induced peripheral nerve hyperexcitability | Q39408791 | ||
| Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial | Q43909975 | ||
| Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial | Q44306113 | ||
| Treatment of Primary and Secondary Liver Cancer by Hepatic Artery Ligation and Infusion Chemotherapy | Q44690565 | ||
| Hepatic artery infusion using oxaliplatin in combination with 5-fluorouracil, folinic acid and mitomycin C: oxaliplatin pharmacokinetics and feasibility. | Q44775436 | ||
| Pharmacokinetic advantage of intra-arterial hepatic oxaliplatin administration: comparative results with cisplatin using a rabbit VX2 tumor model | Q44943010 | ||
| Phase I trial of adjuvant hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone plus systemic oxaliplatin, 5-fluorouracil and leucovorin in patients with resected liver metastases from colorectal cancer | Q46113952 | ||
| Cetuximab with hepatic arterial infusion of chemotherapy for the treatment of colorectal cancer liver metastases. | Q46408816 | ||
| Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer. | Q46595217 | ||
| Assessing the optimal duration of chemotherapy in patients with colorectal liver metastases | Q46616967 | ||
| Hepatic arterial infusion plus systemic irinotecan in patients with unresectable hepatic metastases from colorectal cancer previously treated with systemic oxaliplatin: a retrospective analysis | Q46930577 | ||
| Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). | Q46966631 | ||
| Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure | Q46981494 | ||
| A prospective, randomized evaluation of the treatment of colorectal cancer metastatic to the liver | Q47575070 | ||
| Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases | Q51129985 | ||
| Outcome of Posthepatectomy-Missing Colorectal Liver Metastases after Complete Response to Chemotherapy: Impact of Adjuvant Intra-arterial Hepatic Oxaliplatin | Q60629702 | ||
| The efficacy of hybrid chemotherapy with intravenous oxaliplatin and folinic acid and intra-hepatic infusion of 5-fluorouracil in patients with colorectal liver metastases: a phase II study | Q61054522 | ||
| Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial | Q68424140 | ||
| Oxaliplatin exerts potent in vitro cytotoxicity in colorectal and pancreatic cancer cell lines and liver metastases | Q73151123 | ||
| Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from | Q73358680 | ||
| Antimetabolite-metabolite combination cancer chemotherapy. Effects of intraarterial methotrexate-intramuscular Citrovorum factor therapy in human cancer | Q79280029 | ||
| Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma | Q83195713 | ||
| Regional chemotherapy for hepatic metastases of colorectal carcinoma (continuous intraarterial versus continuous intraarterial/intravenous therapy). Results of a controlled clinical trial | Q93512030 | ||
| P433 | issue | 17 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | fluorouracil | Q238512 |
| bevacizumab | Q413299 | ||
| oxaliplatin | Q422327 | ||
| P304 | page(s) | 4086-4094 | |
| P577 | publication date | 2010-09-01 | |
| P1433 | published in | Cancer | Q326041 |
| P1476 | title | A phase 1 study of hepatic arterial infusion of oxaliplatin in combination with systemic 5-fluorouracil, leucovorin, and bevacizumab in patients with advanced solid tumors metastatic to the liver | |
| P478 | volume | 116 |
| Q33405667 | A phase I study of hepatic arterial infusion of nab-paclitaxel in combination with intravenous gemcitabine and bevacizumab for patients with advanced cancers and predominant liver metastases |
| Q57823392 | Biliary Sclerosis after Hepatic Arterial Infusion Pump Chemotherapy for Patients with Colorectal Cancer Liver Metastasis: Incidence, Clinical Features, and Risk Factors |
| Q33422964 | Dose-finding study of hepatic arterial infusion of irinotecan-based treatment in patients with advanced cancers metastatic to the liver |
| Q37456742 | Evaluation of the clinical relevance of body composition parameters in patients with cancer metastatic to the liver treated with hepatic arterial infusion chemotherapy |
| Q36843737 | First-line treatment with hepatic arterial infusion plus capecitabine vs capecitabine alone for elderly patients with unresectable colorectal liver metastases |
| Q34499002 | Hepatitis C virus-mediated angiogenesis: molecular mechanisms and therapeutic strategies. |
| Q64245421 | Oxaliplatin-Based Intra-arterial Chemotherapy in Colo-Rectal Cancer Liver Metastases: A Review from Pharmacology to Clinical Application |
| Q33392260 | Phase I clinical trial of hepatic arterial infusion of paclitaxel in patients with advanced cancer and dominant liver involvement |
| Q41713124 | The efficacy and safety of hepatic arterial infusion of oxaliplatin plus intravenous irinotecan, leucovorin and fluorouracil in colorectal cancer with inoperable hepatic metastasis |
| Q38664762 | The state of regional therapy in the management of metastatic colorectal cancer to the liver |
Search more.